Origin of the vasculature supporting growth of primary patient tumor xenografts.
about
Current State of Animal (Mouse) Modeling in Melanoma ResearchPatient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsMouse models of colorectal cancer as preclinical modelsEstablishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines.Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine.AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancerBiobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methodsNew cast for a new era: preclinical cancer drug development revisited.Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkersPreclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).Patient-derived Xenografts from Colorectal Carcinoma: A Temporal and Hierarchical Study of Murine Stromal Cell Replacement.Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.
P2860
Q26781652-2A1405B2-61D9-4133-995D-F858CFFD41F4Q26829125-A200B3BE-F938-4262-BDCC-CBA695B0CBEEQ27012618-96ACAA2F-8088-4BAA-8C3D-D487E30382BBQ28081871-C6759498-9CA5-4C94-8939-D848B24AA4ECQ33572502-D9877D1B-FECF-45A4-A175-1F71E053706FQ33875284-90DEE805-B8F7-45F3-A3E6-0318C090DB9EQ35760892-47778431-0231-4160-91C2-6F139E8F0DB9Q35822579-A1A6C4CE-29CC-429F-A50E-E9B1B1C768EDQ35961381-54DAE2FA-3BEB-4E4C-BDE8-D23E1972F6AFQ36123789-32381804-F1FD-47C5-8B05-5AD7712A85DBQ37123902-538E5C0D-0EB7-4F5C-8FDF-845CC4C10132Q37190437-CC0060A9-CB27-4897-968A-DC9C7EB7F8C0Q38834695-4C331078-1A25-4FF2-B35A-4124C4313538Q47161111-19AAFC8F-5332-443E-8B34-546CCC1719E5Q47306839-4F72AC6B-3021-44BD-864E-1CC840D7BB24Q48112414-0E5D3655-9A06-4E21-88D0-5492966AD122Q48365002-ACCCF3F3-2732-46DA-8C44-2E36B18998F3Q52657766-794CBB90-1CDD-4766-BFF0-566D549D6DFF
P2860
Origin of the vasculature supporting growth of primary patient tumor xenografts.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Origin of the vasculature supporting growth of primary patient tumor xenografts.
@en
type
label
Origin of the vasculature supporting growth of primary patient tumor xenografts.
@en
prefLabel
Origin of the vasculature supporting growth of primary patient tumor xenografts.
@en
P2093
P2860
P356
P1476
Origin of the vasculature supporting growth of primary patient tumor xenografts.
@en
P2093
Bonnie L Hylander
Elizabeth A Repasky
Haikuo Tang
Joanna Hillman
Mary Vaughan
Natalie Punt
Rose Pitoniak
Wiam Bshara
P2860
P2888
P356
10.1186/1479-5876-11-110
P577
2013-05-03T00:00:00Z
P5875
P6179
1047121290